anti-VEGF antibody/tyrosine kinase inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-VEGF antibody/tyrosine kinase inhibitors, covering 2025-03-18 to 2025-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/tyrosine Kinase Inhibitors with or Without HAIC for Advanced HCC